Protocol No.: NRG-GU014

Randomized Phase II Trial of Pembrolizumab and Radiation vs Radiation and Concurrent Chemotherapy for High-Grade T1 Bladder Cancer (PARRC)
Principal Investigator
Kolodney, Joanna
Phase
II
Age Group
Adult
Applicable Disease Site
Genitourinary Cancers
Participating Institution
Mary Babb Randolph Cancer Center
Contact
Jill Stone, LPN
Research Specialist
Phone: +1 304-634-4417

View on ClinicalTrials.gov